These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10603664)

  • 1. Epidemiological analysis of immunity to poliovirus after termination of an era of vaccination with OPV in Germany. An analysis of the German Association Against Viral Diseases (DVV).
    Franck S; Allwinn R; Rabenau HF; Doerr HW
    Zentralbl Bakteriol; 1999 Oct; 289(4):475-81. PubMed ID: 10603664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of Poliomyelitis Antibodies Among Children Aged 1 to 4 Years Old and Factors Associated With Poliovirus Susceptibility; Mexican Health and Nutrition Survey, 2012.
    Díaz-Quiñónez JA; Díaz-Ortega JL; Cruz-Hervert P; Ferreira-Guerrero E; Delgado-Sánchez G; Ferreyra-Reyes L; López-Martínez I; Torres-Longoria B; Aparicio-Antonio R; Montero-Campos R; Mongua-Rodríguez N; Garcia-Garcia L
    Clin Infect Dis; 2018 Oct; 67(suppl_1):S110-S114. PubMed ID: 30376082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A seroprevalence study of poliovirus antibody in the population of northern Greece.
    Frantzidou F; Diza E; Halkia D; Antoniadis A
    Clin Microbiol Infect; 2005 Jan; 11(1):68-71. PubMed ID: 15649308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The German Health Interview and Examination Survey for Children and Adolescents (KiGGS): state of immunity against poliomyelitis in German children].
    Diedrich S; Schreier E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007; 50(5-6):771-4. PubMed ID: 17514462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody titers against vaccine and contemporary wild poliovirus type 1 in children immunized with IPV+OPV and young adults immunized with OPV.
    Lukashev AN; Yarmolskaya MS; Shumilina EY; Sychev DA; Kozlovskaya LI
    Virus Res; 2016 Feb; 213():162-164. PubMed ID: 26657881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial.
    Estívariz CF; Jafari H; Sutter RW; John TJ; Jain V; Agarwal A; Verma H; Pallansch MA; Singh AP; Guirguis S; Awale J; Burton A; Bahl S; Chatterjee A; Aylward RB
    Lancet Infect Dis; 2012 Feb; 12(2):128-35. PubMed ID: 22071249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS IN RUSSIAN FEDERATION DURING THE PERIOD OF CHANGES IN VACCINATION SCHEDULE (2006-2013 yy.)].
    Ivanova OE; Eremeeva TP; Morozova NS; Shakaryan AK; Gmyl AP; Yakovenko ML; Korotkova EA; Chernjavskaja OP; Baykova OY; Silenova OV; Krasota AY; Krasnoproshina LI; Mustafina AN; Kozlovskaja LI
    Vopr Virusol; 2016; 61(1):9-15. PubMed ID: 27145594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of different strategies of vaccine prophylaxis for poliomyelitis in the Ukraine].
    Moĭseieva HV; Zadorozhna VI
    Lik Sprava; 2002; (2):85-8. PubMed ID: 12073271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group.
    Modlin JF; Halsey NA; Thoms ML; Meschievitz CK; Patriarca PA
    J Infect Dis; 1997 Feb; 175 Suppl 1():S228-34. PubMed ID: 9203721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass vaccination campaigns to eradicate poliomyelitis in Madagascar: oral poliovirus vaccine increased immunity of children who missed routine programme.
    Andrianarivelo MR; Boisier P; Rabarijaona L; Ratsitorahina M; Migliani R; Zeller H
    Trop Med Int Health; 2001 Dec; 6(12):1032-9. PubMed ID: 11737841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential use of inactivated poliovirus vaccine followed by oral poliovirus vaccine in Oman.
    Sutter RW; Suleiman AJ; Malankar PG; Mehta FR; Medany MA; Arif MA; Linkins RW; Pallansch MA; El-Bualy MS; Robertson SE
    J Infect Dis; 1997 Feb; 175 Suppl 1():S235-40. PubMed ID: 9203722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan.
    Habib M; Soofi S; Ali N; Sutter RW; Palansch M; Qureshi H; Akhtar T; Molodecky NA; Okayasu H; Bhutta ZA
    Vaccine; 2013 Apr; 31(15):1987-93. PubMed ID: 23429005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece.
    Pliaka V; Ruether IG; Kyriakopoulou Z; Kioussi P; Plakokefalos E; Megalou M; Pratti A; Levidiotou-Stefanou S; Markoulatos P
    Clin Microbiol Infect; 2010 Nov; 16(11):1672-5. PubMed ID: 20148919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity against poliomyelitis in the Netherlands, assessed in 2006 to 2007: the importance of completing a vaccination series.
    van der Maas NA; Mollema L; Berbers GA; van Rooijen DM; van der Avoort HG; Conyn-Van Spaendonck MA; de Melker HE; van der Klis FR
    Euro Surveill; 2014 Feb; 19(7):20705. PubMed ID: 24576472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States.
    Chen RT; Hausinger S; Dajani AS; Hanfling M; Baughman AL; Pallansch MA; Patriarca PA
    JAMA; 1996 Jun; 275(21):1639-45. PubMed ID: 8637136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of oral poliomyelitis vaccine (OPV) against variants of wild poliovirus type 3.
    Böthig B; Danes L; Dittmann S
    Bull World Health Organ; 1990; 68(5):597-600. PubMed ID: 1963118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Status of immunity against poliomyelitis. Polio serosurvey in 1993].
    Diedrich S; Schreier E
    Dtsch Med Wochenschr; 1995 Feb; 120(8):239-44. PubMed ID: 7867480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.